MCID: CHR070
MIFTS: 42

Chronic Inflammatory Demyelinating Polyradiculoneuropathy malady

Category: Neuronal diseases

Aliases & Classifications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Aliases & Descriptions for Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

Name: Chronic Inflammatory Demyelinating Polyradiculoneuropathy 11 13
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 68
 
Polyradiculoneuropathy Chronic Inflammatory Demyelinating 50

Classifications:



External Ids:

Disease Ontology11 DOID:5213
ICD1030 G61.81
ICD9CM32 357.81
MeSH39 D020277
NCIt45 C84636

Summaries for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section
MalaCards based summary: Chronic Inflammatory Demyelinating Polyradiculoneuropathy, also known as polyradiculoneuropathy, chronic inflammatory demyelinating, is related to chronic inflammatory demyelinating polyneuropathy and chronic inflammatory demyelinating polyneuritis. An important gene associated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy is MPZ (Myelin Protein Zero), and among its related pathways are Type II interferon signaling (IFNG) and Cytokines and Inflammatory Response. The drug immunoglobulins, intravenous has been mentioned in the context of this disorder. Affiliated tissues include spinal cord, t cells and skin, and related mouse phenotypes are neoplasm and cellular.

Related Diseases for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 125)
idRelated DiseaseScoreTop Affiliating Genes
1chronic inflammatory demyelinating polyneuropathy11.9
2chronic inflammatory demyelinating polyneuritis11.2
3polyradiculoneuropathy11.1
4hereditary orotic aciduria without megaloblastic anaemia10.5MPZ, PMP22
5headache10.5MPZ, PMP22
6secondary hypertrophic osteoarthropathy10.5MPZ, PMP22
7charcot-marie-tooth neuropathy type 2e/1f10.5MPZ, PMP22
8anal canal adenocarcinoma10.5MPZ, PMP22
9potocki-lupski syndrome10.5MPZ, PMP22
10trachea leiomyoma10.5MPZ, PMP22
11angiodysplasia10.5MPZ, PMP22
12thrombophilia due to antithrombin iii deficiency10.5MPZ, PMP22
13muscle cancer10.4ALB, IFNG
14oral cavity carcinoma in situ10.4ALB, IFNG
15diffuse secondary choroid atrophy10.4ALB, IFNG
16anterior foramen magnum meningioma10.4ALB, IFNG
17fibrous histiocytoma10.4ALB, IFNG
18acute necrotizing encephalitis10.4ALB, PMP22
19ovarian papillary cystadenoma10.4MBP, MPZ
20toxocariasis10.4IFNG, IL17A
21niemann-pick disease, type b10.3MBP, MPZ
22neuropathy10.3
23charcot-marie-tooth disease, type 1f10.3MPZ, PMP22
24cryptogenic organizing pneumonia10.3ALB, IL17A
25tetanus neonatorum10.3IFNG, IL17A
26cutis laxa10.3IFNB1, IFNG
27sarcoid meningitis10.3ALB, IFNG
28chronic conjunctivitis10.3IFNG, IL17A
29cutaneous porphyria10.3ALB, IFNG
30orbital periostitis10.3IFNG, IL17A
31corneal intraepithelial neoplasm10.3IFNG, IL17A
32reproductive system disease10.3IFNG, IL17A
33sweat gland cancer10.3ALB, MBP
34necrobiosis lipoidica10.3IFNB1, IL17A
35rhizomelic chondrodysplasia punctata10.3IFNG, IL17A
36gastric ulcer10.3ALB, IFNG
37wissler's syndrome10.2IFNG, IL17A
38paranasal sinus sarcoma10.2ALB, IFNG
39burn scar10.2IFNG, IL17A
40brain meningioma10.2ALB, MBP
41dentinogenesis imperfecta10.2ALB, IFNG
42multifocal motor neuropathy10.2
43newborn respiratory distress syndrome10.2IL17A, MBP
44pancreatic vasoactive intestinal peptide producing tumor10.2ALB, MPZ, PMP22
45cogan-reese syndrome10.2IFNB1, MBP
46squamous cell papilloma10.2ALB, MPZ, PMP22
47bile duct cystadenoma10.2IFNB1, MBP
48systemic lupus erythematosus10.2
49lupus erythematosus10.2
50variola minor10.1ALB, IFNG

Graphical network of the top 20 diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:



Diseases related to chronic inflammatory demyelinating polyradiculoneuropathy

Symptoms & Phenotypes for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

MGI Mouse Phenotypes related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.6ALB, CXCR4, IFNB1, IFNG, PRF1
2MP:00053847.9ALB, CXCR4, IFNG, MBP, MPZ, PMP22
3MP:00036317.7CXCR4, IFNB1, IFNG, MBP, MPZ, PMP22
4MP:00053977.7CXCR4, IFNB1, IFNG, IL17A, MBP, MPZ
5MP:00053877.7CXCR4, IFNB1, IFNG, IL17A, MBP, MPZ
6MP:00053897.5CXCR4, IFNG, MBP, MPZ, PMP22, PRF1
7MP:00107687.4ALB, CXCR4, IFNG, IL17A, MBP, MPZ
8MP:00053767.3ALB, CXCR4, IFNB1, IFNG, IL17A, MBP

Drugs & Therapeutics for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Drugs for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 44)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
alemtuzumabapproved, investigationalPhase 4303216503-57-0
Synonyms:
Campath
 
MabCampath
alemtuzumab
2Immunoglobulins, IntravenousPhase 4, Phase 3, Phase 2324
3Rho(D) Immune GlobulinPhase 4, Phase 3, Phase 2317
4ImmunoglobulinsPhase 4, Phase 3, Phase 2, Phase 16045
5gamma-GlobulinsPhase 4, Phase 3, Phase 2317
6AntibodiesPhase 4, Phase 3, Phase 2, Phase 16045
7
Prednisoneapproved, vet_approvedPhase 3135953-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
8
Mycophenolate mofetilapproved, investigationalPhase 3939128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
9
Mycophenolic acidapprovedPhase 393924280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
 
Melbex
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
10
BenzocaineapprovedPhase 318921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
11
Glycineapproved, nutraceutical, vet_approvedPhase 322656-40-6750
Synonyms:
(1-13c)glycinato
(15N)Glycine
15527_RIEDEL
15527_SIAL
15743-44-9 (mono-potassium salt)
17829-66-2 (cobalt salt)
18875-39-3
2,2-dialkylglycines
2-Aminoacetate
2-Aminoacetic acid
2311-65-1
25718-94-9
29728-27-6 (monoammonium salt)
32817-15-5 (copper salt)
33226_RIEDEL
33226_SIAL
33242-26-1 (calcium salt)
35947-07-0 (calcium salt (2:1))
410225_SIAL
50046_FLUKA
50046_SIGMA
513-29-1 (sulfate (3:1))
52955-63-2
56-40-6
57678-19-0
6000-43-7 (hydrochloride)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
71295-98-2 (phosphate (1:1))
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
7575-55-5
848646-45-7
87867-94-5
AB-131/40217813
AB1002628
AC1L19XW
AC1Q28JW
AC1Q53O0
AI3-04085
AKOS000119626
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
AR-1A0345
AR-1A0532
Acide aminoacetique
Acide aminoacetique [INN-French]
Acido aminoacetico
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum
Acidum aminoaceticum [INN-Latin]
Aciport
Amino-Acetate
Amino-Acetic acid
Aminoacetate
Aminoacetic acid
Aminoazijnzuur
Aminoessigsaeure
Aminoethanoate
Aminoethanoic acid
Amitone
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
BPBio1_001222
Biomol-NT_000195
C00037
CCRIS 5915
CHEBI:15428
CHEBI:15705
CHEBI:16228
CHEMBL773
CID750
CPD-8569
Corilin
D00011
DB00145
EINECS 200-272-2
 
FEMA No. 3287
FT-0083159
G
G0099
G0317
G5417_SIGMA
G5523_SIGMA
G7126_SIGMA
G7403_SIGMA
G8790_SIGMA
G8898_SIGMA
GLY (IUPAC abbrev)
GLYCINE 1.5% IN PLASTIC CONTAINER
GLYCINE, ACS
Glicina
Glicina [INN-Spanish]
Glicoamin
Gly
Glycin
Glycine
Glycine (JP15/USP)
Glycine [INN]
Glycine iron sulphate (1:1)
Glycine, homopolymer (VAN)
Glycine, labeled with carbon-14
Glycine, non-medical
Glycine-UL-14C hydrochloride
Glycinum
Glycinum [INN-Latin]
Glycocoll
Glycolixir
Glycosthene
Glykokoll
Glyzin
Gyn-Hydralin
Gyn-hydralin
H-Gly-OH
H2N-CH2-COOH
HSDB 495
Hampshire glycine
Hgly
InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5
KST-1A2919
KST-1A8102
L-Glycine
L-alpha-amino acids
L001246
LS-218
Leimzucker
MolPort-000-871-607
NCGC00024503-01
NCGC00024503-02
NChemBio.2007.13-comp1
NSC 25936
NSC25936
P8791_SIGMA
Padil
Polyglycine II
S04-0135
Sucre de gelatine
Tocris-0219
UNII-TE7660XO1C
W328707_ALDRICH
WLN: Z1VQ
aminoacetic acid
an alpha amino acid ester
bmse000089
gly
glycine
nchem.554-comp2
nchembio.121-comp9
nchembio.145-comp33
nchembio.198-comp12
nchembio.265-comp9
nchembio.266-comp30
polyglycine
12tannic acidapproved, NutraceuticalPhase 31892
133,4-diaminopyridinePhase 319
14Potassium Channel BlockersPhase 3176
15Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 212767
16Antineoplastic Agents, HormonalPhase 35407
17Immunoglobulin GPhase 3265
18Immunosuppressive AgentsPhase 3, Phase 212770
19Anti-Inflammatory AgentsPhase 310355
20HormonesPhase 3, Phase 213979
21Hormone AntagonistsPhase 3, Phase 212778
22glucocorticoidsPhase 34920
23Fingolimod HydrochloridePhase 387
24Pharmaceutical SolutionsPhase 3, Phase 27793
25Antibiotics, AntitubercularPhase 36972
26Anti-Bacterial AgentsPhase 310884
27
Interferon beta-1aapproved, investigationalPhase 2198145258-61-36438354
Synonyms:
145258-61-3
Avonex
Avonex (TN)
Belerofon
D04554
 
Fibroblast interferon
IFN-beta
Interferon beta precursor
Interferon beta-1a
Interferon beta-1a (USAN)
Interferon beta-1a (genetical recombination)
Interferon beta-1a (genetical recombination) (JAN)
28
Folic Acidapproved, nutraceutical, vet_approvedPhase 2427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
29MicronutrientsPhase 25802
30Protective AgentsPhase 27190
31Thioctic AcidPhase 2115
32Vitamin B ComplexPhase 24229
33Trace ElementsPhase 25802
34VitaminsPhase 25095
35Anti-Infective AgentsPhase 221402
36Adjuvants, ImmunologicPhase 22484
37Antiviral AgentsPhase 29732
38Interferon-betaPhase 2280
39AntioxidantsPhase 22928
40interferonsPhase 22137
41Vitamin B9NutraceuticalPhase 24279
42FolateNutraceuticalPhase 24279
43Alpha-lipoic AcidNutraceuticalPhase 2115
44Antibodies, Anti-Idiotypic18

Interventional clinical trials:

(show all 41)
idNameStatusNCT IDPhase
1Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)Unknown statusNCT01757574Phase 4
2IVIg for Demyelination in Diabetes MellitusRecruitingNCT02372149Phase 4
3Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.CompletedNCT01625182Phase 3
4Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.CompletedNCT01824251Phase 3
5Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT01184846Phase 3
6Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)CompletedNCT01545076Phase 3
7Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00220740Phase 3
8Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00004772Phase 3
9Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIgCompletedNCT01349270Phase 3
10Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating NeuropathyCompletedNCT00004286Phase 3
11Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating PolyneuropathyCompletedNCT00004939Phase 3
12Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDPRecruitingNCT02955355Phase 3
13Efficacy and Safety Study of I10E in Treatment of Patients With CIDPRecruitingNCT02293460Phase 3
14Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302RecruitingNCT02317562Phase 3
15Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDPRecruitingNCT02549170Phase 3
16Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Active, not recruitingNCT02027701Phase 3
17Interest of Mycophenolate for CIDP WeaningActive, not recruitingNCT02494505Phase 3
18Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) NeuropathyNot yet recruitingNCT02638207Phase 3
19Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDPTerminatedNCT01225276Phase 2, Phase 3
20Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT00099489Phase 2
21Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT01017159Phase 2
22Lipoic Acid to Treat Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00962429Phase 2
23Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00001287Phase 2
24Stem Cell Transplantation for Stiff Person Syndrome (SPS)RecruitingNCT02282514Phase 1, Phase 2
25SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot StudyRecruitingNCT02967679Phase 1, Phase 2
26Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating PolyneuropathyActive, not recruitingNCT00278629Phase 2
27High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating PolyneuropathyWithdrawnNCT01236456Phase 2
28Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating NeuropathyWithdrawnNCT02574962Phase 2
29Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating PolyneuropathyUnknown statusNCT01379833
30MRI in Diagnosing and Monitoring CIDPCompletedNCT02017769
31Study of CIDP Patients During IVIG TreatmentCompletedNCT00305266
32Effect of Resistance and Aerobic Exercise in CIDP or MMNCompletedNCT02121678
33Immunoglobulin Dosage and Administration Form in CIDP and MMNCompletedNCT02111590
34Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT02629796
35Transcriptome Analysis of the Peripheral Blood in CIDPRecruitingNCT02404298
36Subcutaneous Immunoglobulin for CIDPRecruitingNCT02465359
37IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength MeasurementsRecruitingNCT02414490
38sCD163 & CD19 as Candidate Biomarkers in CIDP and MMNRecruitingNCT02271724
39Magnetic Resonance Diagnostics of Diabetic Peripheral NeuropathyRecruitingNCT01847937
40Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous ImmunoglobulinNot yet recruitingNCT02892890
41Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and NeuroNot yet recruitingNCT03008733

Search NIH Clinical Center for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Inferred drug relations via UMLS68/NDF-RT46:

Genetic Tests for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Anatomical Context for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

MalaCards organs/tissues related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

36
Spinal cord, T cells, Skin, Brain, Tongue, Nk cells, Thyroid

Publications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Articles related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

(show top 50)    (show all 305)
idTitleAuthorsYear
1
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. (28084646)
2017
2
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. (26873805)
2016
3
Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand. (27113227)
2016
4
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-BarrAc syndrome: a case report. (27380808)
2016
5
Fatigue, Pain, Anxiety and Depression in Guillain-BarrAc Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy. (27077919)
2016
6
Intravenous Immunoglobulins Lower Inflammatory Gene Expression in Skin Biopsies of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. (27286956)
2016
7
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies. (27902997)
2016
8
IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay. (27852440)
2016
9
Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy. (27230584)
2016
10
Transcriptome Analysis of Peripheral Blood in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients Identifies TNFR1 and TLR Pathways in the IVIg Response. (27175635)
2016
11
A Bodybuilder With Weak Hands and Feet: Corticosteroid-Responsive Pure Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy Following Anabolic Steroid Use. (27438336)
2016
12
Multiple Myeloma Associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Importance of Continued Surveillance. (28070468)
2016
13
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop. (27241239)
2016
14
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data. (27313890)
2016
15
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. (27211560)
2016
16
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. (27781132)
2016
17
Chronic inflammatory demyelinating polyradiculoneuropathy: A new animal model for new therapeutic targets. (27838091)
2016
18
A case of a 17-year-old male with neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy presenting with tremor and ataxia. (27580761)
2016
19
A case of chronic inflammatory demyelinating polyradiculoneuropathy after treatment with pegylated interferon I+-2a in a patient with chronic hepatitis B virus infection. (27680223)
2016
20
Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy. (26977594)
2016
21
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)? (26750580)
2016
22
A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA. (27580763)
2016
23
Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. (25571892)
2015
24
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog. (26450833)
2015
25
Characteristic MRI features of chronic inflammatory demyelinating polyradiculoneuropathy. (25687202)
2015
26
Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. (26203970)
2015
27
Maintenace therapy in chronic inflammatory demyelinating polyradiculoneuropathy. (26088325)
2015
28
Which criteria for research in chronic inflammatory demyelinating polyradiculoneuropathy? an analysis of current practice. (25354388)
2015
29
Chronic inflammatory demyelinating polyradiculoneuropathy with cranial nerves hypertrophy, thyroid-related orbitopathy and IgG monoclonal gammopathy: a case report. (25647292)
2015
30
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies. (26392214)
2015
31
Long-term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. (25556954)
2015
32
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. (25561247)
2015
33
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. (25677463)
2015
34
New insights into the management of chronic inflammatory demyelinating polyradiculoneuropathy. (26107324)
2015
35
Relapse with Dysphagia in a Case of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. (26179538)
2015
36
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. (26305459)
2015
37
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice. (26437234)
2015
38
The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis. (26198918)
2015
39
The diagnostic value of MRI in pediatric chronic inflammatory demyelinating polyradiculoneuropathy. (25972306)
2015
40
Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy. (24887608)
2014
41
Intravenous immunoglobulin response in treatment-naA^ve chronic inflammatory demyelinating polyradiculoneuropathy. (25515502)
2014
42
Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. (25200479)
2014
43
Ophthalmic nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy. (24778284)
2014
44
Spinal cord involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and MRI study. (24988899)
2014
45
Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy. (25354579)
2014
46
Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. (24612201)
2014
47
Progressive bilateral ptosis in a patient with midbrain metastasis and chronic inflammatory demyelinating polyradiculoneuropathy. (24594646)
2014
48
Genetics of Guillain-BarrAc syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions. (25039604)
2014
49
Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review. (24507546)
2014
50
Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes. (25105500)
2014

Variations for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Expression for genes affiliated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section
Search GEO for disease gene expression data for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Pathways for genes affiliated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

GO Terms for genes affiliated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Cellular components related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1compact myelinGO:004321810.3MBP, PMP22
2myelin sheathGO:00432099.1ALB, MBP, MPZ
3extracellular regionGO:00055768.5ALB, IFNB1, IFNG, IL17A, PRF1

Biological processes related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1cell deathGO:000821910.4IL17A, PMP22
2positive regulation of interleukin-23 productionGO:003274710.2IFNG, IL17A
3positive regulation of osteoclast differentiationGO:004567210.2IFNG, IL17A
4positive regulation of peptidyl-serine phosphorylation of STAT proteinGO:003314110.1IFNB1, IFNG
5myelinationGO:004255210.1MBP, PMP22
6response to mercury ionGO:004668910.0ALB, MBP
7chemical synaptic transmissionGO:00072689.8MBP, MPZ, PMP22
8cell surface receptor signaling pathwayGO:00071669.8IFNB1, IFNG, IL17A
9defense response to virusGO:00516079.3IFNB1, IFNG, PRF1
10response to virusGO:00096159.1CXCR4, IFNB1, IFNG
11apoptotic processGO:00069159.0CXCR4, IFNG, IL17A, PRF1

Molecular functions related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051259.1IFNB1, IFNG, IL17A

Sources for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet